Aloe-emodin loaded solid lipid nanoparticles: Formulation design and in vitro anti-cancer study

Drug Delivery

Volumn 22, Issue 5, 2015, Pages 666-674

  Chen, Ruie ^a   Wang, Shengpeng ^a   Zhang, Jinming ^a   Chen, Meiwan ^a   Wang, Yitao ^a  

^a UNIVERSITY OF MACAU   (Macao)

Author keywords

Aloe emodin; Anti tumor activity; Apoptosis; Formulation; Solid lipid nanoparticles

Indexed keywords

ALOE EMODIN; HOE 33342; LIPOCORTIN 5; SOLID LIPID NANOPARTICLE; SUCCINATE DEHYDROGENASE; ANTHRAQUINONE DERIVATIVE; LIPID; NANOPARTICLE;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CHEMICAL MODIFICATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; HEPG2 CELL LINE; HIGH PRESSURE HOMOGENIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; PARTICLE SIZE; PRESCRIPTION; PRIORITY JOURNAL; STAINING; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; MEDICINAL CHEMISTRY;

ANTHRAQUINONES; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DRUG SCREENING ASSAYS, ANTITUMOR; HEP G2 CELLS; HUMANS; IN VITRO TECHNIQUES; LIPIDS; MCF-7 CELLS; NANOPARTICLES;

EID: 84937829315     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.882446     Document Type: Article

References (26)

1. Almeida AJ, Souto E. (2007). Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 59: 478-90.
2. Chen HC, Hsieh WT, Chang WC, et al. (2004). Aloe-emodin induced in vitro g2/m arrest of cell cycle in human promyelocytic leukemia hl-60 cells. Food Chem Toxicol 42:1251-7.
3. Chen SH, Lin KY, Chang CC, et al. (2007). Aloe-emodin-induced apoptosis in human gastric carcinoma cells. Food Chem Toxicol 45: 2296-303.
4. Chen YY, Chiang SY, Lin JG, et al. (2010). Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer scc-4 cells through the inhibition of gene expression of matrix metalloproteinase- 9. Int J Oncol 36:1113-20.
5. Chou TH, Liang CH. (2009). The molecular effects of aloe-emodin (ae)/liposome-ae on human nonmelanoma skin cancer cells and skin permeation. Chem Res Toxicol 22:2017-28.
6. Collier AC, Pritsos CA. (2003). The mitochondrial uncoupler dicumarol disrupts the mtt assay. Biochem Pharmacol 66:281-7.
7. Del Pozo-rodriguez A, Solinis MA, Gascon AR, et al. (2009). Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm 71:181-9.
8. Guo Y, Cui DS, Wang ZM. (2009). Determination of binding constant between b-cyclodextrin and aloe-emodin by capillary electrophoresis. Chin J App Chem 26:492-4.
9. Harlev E, Nevo E, Lansky EP, et al. (2012). Anticancer potential of aloes: antioxidant, antiproliferative, and immunostimulatory attributes. Planta Medica 78:843-52.
10. Kiechle FL, Zhang X. (2002). Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta 326:27-45.
11. Li YC, Dong L, Jia A, et al. (2006). Preparation of solid lipid nanoparticles loaded with traditional chinese medicine by highpressure homogenization. Nan Fang Yi Ke Da Xue Xue Bao 26: 541-4.
12. Mehnert W, Mader K. (2012). Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev 64:83-101.
13. Muller RH, Mader K, Gohla S. (2000). Solid lipid nanoparticles (sln) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 50:161-77.
14. Noack A, Hause G, Mader K. (2012). Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles. Int J Pharm 423: 440-51.
15. Patel M, Souto EB, Singh KK. (2013). Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles. Expert Opin Drug Deliv 10:889-905.
16. Pecere T, Sainella F, Saltata C, et al. (2003). Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin. Int J Cancer 106:836-47.
17. Rajewski RA, Stella VJ. (1996). Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 85:1142-69.
18. Schutte B, Nuydens R, Geerts H, et al. (1998). Annexin V binding assay as a tool to measure apoptosis in differentiated neuronal cells. J Neurosci Methods 86:63-9.
19. Siegel R, Naishadham D, Jemal A. (2012). Cancer statistics, 2012. CA-Cancer J Clin 62:10-29.
20. Szulc J, Dudzik M, Woyczikowski B, et al. (2002). Liposomes - therapeutic progress and technological problems. Pol Merkur Lekarski 12:164-8.
21. Wang J, Chen J, Ye N, et al. (2012a). Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (slns). Curr Drug Metab 13:447-56.
22. Wang Q, Wang Y, Wang LF. (2009). Phamacokinetic study of solid lipid nanoparticles as drug delivery systems. Gansu J Tradit Chin Med 22: 79-81.
23. Wang SP, Chen TK, Chen RE, et al. (2012b). Emodin loaded solid lipid nanoparticles: Preparation, characterization and antitumor activity studies. Int J Pharm 430:238-46.
24. Wang SP, Zhong ZF, Wan JB, et al. (2013). Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells. Am J Chin Med 41:177-96.
25. Yuan H, Miao J, Du YZ, et al. (2008). Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in a549 cancer cells. Int J Pharm 348:137-45.
26. Zhang HB, Zhu XY, Zhang TJ. (2011). Advances in study on nanotechnology used in chinese materia medica preparation. Drugs Clinic 26:208-11.